I picked this one up last week alongside $EDIT 

Both are into gene-editing.

It looks like CRSP is a bit farther ahead than EDIT, thus a bigger market cap.

I like the lower market cap of EDIT a bit more.

This is all new to me, though.  I'll be doing some more in depth research this week on both to figure out how to size up (or down).